FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to pulmonology, resuscitation and rehabilitation, and can be used for completion of oxygen therapy and patient transfer to constant air breathing. Method consists in alternating air breathing and oxygen therapy, wherein oxygen flow is regulated to achieve preset levels of haemoglobin oxygen saturation in peripheral blood with continuous monitoring until complete cessation of oxygen supply. Oxygen therapy is carried out in a sitting position with a maximum vertical back. After verticalisation, patient performs 2 to 5 respiratory cycles of lung expansion for 3 minutes. Each cycle includes a quiet passive exhalation, maximum deep stepped inhalation, breath holding at the inhalation height for 1-3 sec, free passive exhalation, period of 0.1-0.5 minutes of normal breathing between passive exhalation and the next deep inhalation. Then, depending on the use or non-use of the ventilator during the oxygen therapy for 7 minutes, the minimum flow of insufflated oxygen F or the minimum FiO2 of the non-invasive assisted artificial pulmonary ventilation (NAAPV) apparatus is adjusted, which provides stable maintenance of SpO2 97% or 94% for patients with chronic respiratory failure (CRF). Obtained value of F or FiO2 is recorded. Thereafter, the oxygen therapy is terminated by removing the respiratory mixture supply device or by reducing FiO2 of the NAAPV apparatus to 0.21 without removing the respiratory mixture supply device. time of decrease of SpO2 by 10% (tdesat) is recorded. Further, the oxygen therapy or NAAPV is resumed with the parameters recorded after the respiratory cycles of pulmonary expansion. Above sequence of actions is carried out hourly, except for periods of night and day sleep. Depending on the value of tdesat after each session, the degree of oxygen dependence (OD) is determined. Starting from the second session, the current value of tdesat is compared with its previous value, and depending on the dynamics of tdesat, intensification, fixation or weakening of the oxygenating function of the lungs is determined. Oxygen therapy parameters are varied depending on the degree of OD and OFL. Alternation of respiratory cycles of pulmonary expansion and oxygen therapy is repeated until reaching indications for completion of oxygen therapy.
EFFECT: invention enables monitoring and restoring the oxygenating function of the lungs taking into account the individual characteristics of the patient.
1 cl, 3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OXYGEN THERAPY DURING SPONTANEOUS BREATHING IN CORONAVIRUS INFECTION | 2022 |
|
RU2787834C1 |
MINIMAL FLOW INHALATIONAL ANESTHESIA METHOD | 2007 |
|
RU2345773C2 |
METHOD FOR TERMINATION OF LONG-TERM ARTIFICIAL PULMONARY VENTILATION IN CANNULATED PATIENTS WITH HIGH RISK OF INEFFECTIVE WEANING FROM RESPIRATOR | 2023 |
|
RU2819519C1 |
METHOD OF ANESTHETIC PROTECTION AGAINST SURGICAL AGGRESSION FACTORS | 2006 |
|
RU2332215C2 |
METHOD FOR PREVENTING DECOMPENSATED RESPIRATORY FAILURE FOLLOWING RADICAL SURGICAL TREATMENT OF LUNG CANCER IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2023 |
|
RU2829259C1 |
METHOD FOR THE TREATMENT OF RESPIRATORY FAILURE AFTER ACUTE RESPIRATORY DISTRESS SYNDROME, REGARDLESS OF ETIOLOGY | 2022 |
|
RU2782103C1 |
METHOD FOR CORRECTING HYPOXEMIA DURING ONE-LUNG VENTILATION USING HIGH-FLOW OXYGEN INSUFFLATION IN PATIENTS WITH LUNG CANCER | 2022 |
|
RU2792742C1 |
METHOD OF TREATING PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19 WITH SPONTANEOUS RESPIRATION | 2023 |
|
RU2824264C1 |
METHOD OF CHOOSING TACTICS FOR CORRECTING ACUTE RESPIRATORY FAILURE IN PATIENTS WITH COVID-19 | 2023 |
|
RU2807934C1 |
METHOD FOR DETERMINATION OF READINESS OF WEANING FROM EQUIPMENT OF ARTIFICIAL VENTILATION OF LIGHT PATIENTS WITH CEREBRAL INJURIES | 2018 |
|
RU2693442C1 |
Authors
Dates
2025-04-30—Published
2024-12-03—Filed